SCHEMBL5733423

SCHEMBL5733423

COc1cc2c(cc1OC)C(CCc1c(Cl)cccc1Cl)NCC2

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
GRIN2D O15399 7/20 0.54
GRIN3B O60391 7/20 0.54
GRIN1 Q05586 7/20 0.54
GRIN2A Q12879 7/20 0.54
GRIN2B Q13224 7/20 0.54
GRIN2C Q14957 7/20 0.54
GRIN3A Q8TCU5 7/20 0.54
MEN1 O00255 2/20 0.53
BCHE P06276 1/20 0.53
RAB9A P51151 1/20 0.52
KDM4C Q9H3R0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026206 1.00 KMT2A (0.54) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4024107 0.92 KMT2A (0.57) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6392785 0.88 BCHE (0.61) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4023954 0.86 KMT2A (0.62) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4024891 0.85 KDM4C (0.52) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4025070 0.84 GRIN2D (0.54) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4712855 0.82 BCHE (0.58) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4030387 0.82 BCHE (0.58) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4026150 0.82 GRIN2D (0.64) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL5734195 0.82 GRIN2D (0.64) KMT2AGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611104-A1 TETRAHYDROISOQUINOLYL ACETAMIDE DERIVATIVES FOR USE AS OREXIN RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2006-01-04 EP disclosed
WO-2004085403-A1 TETRAHYDROISOQUINOLYL ACETAMIDE DERIVATIVES FOR USE AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2004-10-07 WO disclosed